Talk to an expert
Envelope Linkedin

Explore Starodub latest updates

Get in touch
View our whitepapers
  • Updates

The Difference Between a Toothbrush and a Dermal Filler? Regulation
  • Updates

New website for reliable medicine information: Medicijncheck.nl
  • Updates

An interesting case in the Dutch pharmaceutical landscape
  • Updates

Most Scientific Advice meetings don’t fail because of the answers. They fail because of the questions.
  • Updates

Is your medical device truly ready for the next audit or MDR assessment?
  • Updates

The biggest risk in Regulatory Affairs: AI illiteracy.
  • Updates

The CESP outage: a wake-up call for submission resilience
  • Updates

Can a medical device contain herbal substances – or does “herbal” automatically mean “medicinal product”?
  • Updates

The most expensive regulatory deficiency is the one you discover after submitting your dossier. How much could a regulatory delay cost your development program?
  • Updates

Women’s Health is Finally Moving Towards the Regulatory Attention it Deserves
  • Updates

Your Product Might Be Safe. Is Your IFU?
  • Updates

EU drug-device combination products (DDC): regulatory aspects start early
  • Updates

Investing in ATMP or Biologics? Regulatory risk is value critical.
  • Updates

Four challenges from MEB’s State of Implementation report
  • Updates

Transitioning to the EU In Vitro Diagnostic Regulation: is your IVD technical documentation ready for submission?
  • Updates

Starodub eCTD Team
  • Updates

Medical device market access in the EU: national obligations beyond EUDAMED
  • Updates

Regulatory support for ATMP & Biologics developers
Load more updates
Gilliian Marland
Senior RA Consultant
Gilliian Marland

Let's Connect

Talk to an expert